PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Clinical trials for PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA explained in plain language.

Never miss a new study

Get alerted when new PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA trials appear

Sign up with your email to follow new studies for PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug trial targets rare blood disorder that destroys red cells

Disease control Ongoing

This study is testing an investigational injection called LP-005 in adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease where the immune system attacks and destroys red blood cells. Researchers will measure if the treatment reduces blood cell destruction, …

Matched conditions: PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control

Last updated Mar 17, 2026 13:08 UTC

PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Get alerted when new PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA trials appear

New drug trial targets rare blood disorder that destroys red cells